Literature DB >> 28089905

Nudix-type motif 2 contributes to cancer proliferation through the regulation of Rag GTPase-mediated mammalian target of rapamycin complex 1 localization.

Ohman Kwon1, Dongoh Kwak2, Sang Hoon Ha2, Hyeona Jeon2, Mangeun Park1, Yeonho Chang2, Pann-Ghill Suh3, Sung Ho Ryu4.   

Abstract

Lysosomal localization of mammalian target of rapamycin complex 1 (mTORC1) is a critical step for activation of the molecule. Rag GTPases are essential for this translocation. Here, we demonstrate that Nudix-type motif 2 (NUDT2) is a novel positive regulator of mTORC1 activation. Activation of mTORC1 is impaired in NUDT2-silenced cells. Mechanistically, NUDT2 binds to Rag GTPase and controls mTORC1 translocation to the lysosomal membrane. Furthermore, NUDT2-dependent mTORC1 regulation is critical for proliferation of breast cancer cells, as NUDT2-silenced cells arrest in G0/G1 phases. Taken together, these results show that NUDT2 is a novel complex formation enhancing factor regulating mTORC1-Rag GTPase signaling that is crucial for cell growth control.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer cell proliferation; Lysosomal localization; Mammalian target of rapamycin complex 1 (mTORC1); Nudix-type motif 2 (NUDT2); Rag GTPases

Mesh:

Substances:

Year:  2017        PMID: 28089905     DOI: 10.1016/j.cellsig.2017.01.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

Review 1.  Metformin and Breast Cancer: Molecular Targets.

Authors:  J Faria; G Negalha; A Azevedo; F Martel
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-03-22       Impact factor: 2.673

2.  A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family.

Authors:  Jordi Carreras-Puigvert; Marinka Zitnik; Ann-Sofie Jemth; Megan Carter; Judith E Unterlass; Björn Hallström; Olga Loseva; Zhir Karem; José Manuel Calderón-Montaño; Cecilia Lindskog; Per-Henrik Edqvist; Damian J Matuszewski; Hammou Ait Blal; Ronnie P A Berntsson; Maria Häggblad; Ulf Martens; Matthew Studham; Bo Lundgren; Carolina Wählby; Erik L L Sonnhammer; Emma Lundberg; Pål Stenmark; Blaz Zupan; Thomas Helleday
Journal:  Nat Commun       Date:  2017-11-16       Impact factor: 14.919

Review 3.  The Architecture of the Rag GTPase Signaling Network.

Authors:  Raffaele Nicastro; Alessandro Sardu; Nicolas Panchaud; Claudio De Virgilio
Journal:  Biomolecules       Date:  2017-06-30

Review 4.  Role of the NUDT Enzymes in Breast Cancer.

Authors:  Roni H G Wright; Miguel Beato
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

5.  Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians.

Authors:  Yingchang Lu; Sun-Seog Kweon; Qiuyin Cai; Chizu Tanikawa; Xiao-Ou Shu; Wei-Hua Jia; Yong-Bing Xiang; Jeroen R Huyghe; Tabitha A Harrison; Jeongseon Kim; Aesun Shin; Dong-Hyun Kim; Keitaro Matsuo; Sun Ha Jee; Xingyi Guo; Wanqing Wen; Jiajun Shi; Bingshan Li; Nan Wang; Min-Ho Shin; Hong-Lan Li; Zefang Ren; Jae Hwan Oh; Isao Oze; Yoon-Ok Ahn; Keum Ji Jung; Jing Gao; Yu-Tang Gao; Zhi-Zhong Pan; Yoichiro Kamatani; Andrew T Chan; Andrea Gsur; Jochen Hampe; Loic Le Marchand; Li Li; Annika Lindblom; Victor Moreno; Polly A Newcomb; Kenneth Offit; Paul D P Pharoah; Franzel J B van Duijnhoven; Bethany Van Guelpen; Pavel Vodicka; Stephanie J Weinstein; Alicja Wolk; Anna H Wu; Li Hsu; Yi-Xin Zeng; Jirong Long; Ulrike Peters; Koichi Matsuda; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-11       Impact factor: 4.254

6.  Novel NUDT2 variant causes intellectual disability and polyneuropathy.

Authors:  Frank Diaz; Shaweta Khosa; Dmitriy Niyazov; Hane Lee; Richard Person; Michelle M Morrow; Rebecca Signer; Naghmeh Dorrani; Allison Zheng; Matthew Herzog; Robert Freundlich; J Brandon Birath; Yurivia Cervantes-Manzo; Julian A Martinez-Agosto; Christina Palmer; Stanley F Nelson; Brent L Fogel; Shri K Mishra
Journal:  Ann Clin Transl Neurol       Date:  2020-10-15       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.